跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ERTAPENEM FOR INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ERTAPENEM FOR INJECTION
Authorized
STANDARD
ERTAPENEM FOR INJECTION
fresenius kabi canada ltd
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
a590b47114385288
Company
fresenius kabi canada ltd
Type
Standard
Approval Details
Approval Id
a590b47114385288
Drug Approval Canada Name
ERTAPENEM FOR INJECTION
Product Name
ERTAPENEM FOR INJECTION
Status
Marketed
Status Date
2021-06-07
Original Market Date
2021-06-07
Din
02496127
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous , Intramuscular
Schedule
Prescription
Ahfs
08:12.07.08
Atc Original
J01DH03 ERTAPENEM
Atc Name
j 01 dh 03
Aig Number
0149104002
Company Name
fresenius kabi canada ltd
Company Address
165 Galaxy Blvd, Suite 100, Toronto, Ontario, Canada, M9W 0C8
Active Ingredients
ERTAPENEM (ERTAPENEM SODIUM)
1 G / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
a590b47114385288
Type
Standard
Back to Health Canada Approvals